Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-08 Purchase |
2021-12-09 4:18 pm |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
10,000 | $9.3885 | $93,885 | 10,000 (Direct) |
View |
| 2021-11-18 Purchase |
2021-11-19 1:21 pm |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
15,700 | $12.74 | $200,018 | 15,700 (Indirect) |
View |
| 2021-10-13 Purchase |
2021-10-15 5:37 pm |
Pyxis Oncology Inc. | PYXS | Chin Mark Director |
312,500 | $16 | $5,000,000 | 1,745,761 (Indirect) |
View |
| 2021-10-13 Purchase |
2021-10-15 4:12 pm |
Pyxis Oncology Inc. | PYXS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
450,000 | $16 | $7,200,000 | 1,118,854 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-06 Option Award |
2021-12-07 3:36 pm |
N/A 2031-12-06 |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
52,944 | $0 | 52,944 (Direct) |
View |
| 2021-10-13 Conversion |
2021-10-15 5:37 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Chin Mark Director |
10,547,370 | $0 | 1,745,761 (Indirect) |
View |
| 2021-10-13 Conversion |
2021-10-15 5:35 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director |
17,578 | $0 | 171,610 (Direct) |
View |
| 2021-10-13 Conversion |
2021-10-15 5:05 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT Former 10% Owner |
20,180,872 | $0 | 2,742,338 (Direct) |
View |
| 2021-10-13 Conversion |
2021-10-15 4:12 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
668,854 | $0 | 1,118,854 (Indirect) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
42,191 | $0 | 42,191 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director |
42,191 | $0 | 42,191 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
42,191 | $0 | 42,191 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer |
480,679 | $0 | 480,679 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Chin Mark Director |
42,191 | $0 | 42,191 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director |
42,191 | $0 | 42,191 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
962,289 | $0 | 962,289 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Herbst Ronald Chief Scientific Officer |
28,252 | $0 | 28,252 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Shah Ritu Chief Operating Officer |
31,344 | $0 | 31,344 (Direct) |
View |
Ownership |
2021-10-07 9:28 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
0 | $0 | 1,351,075 (Direct) |
View |
Ownership |
2021-10-07 9:25 pm |
N/A 2031-03-30 |
Pyxis Oncology Inc. | PYXS | Shah Ritu Chief Operating Officer |
0 | $0 | 265,024 (Direct) |
View |
Ownership |
2021-10-07 9:21 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director |
0 | $0 | 187,335 (Direct) |
View |
Ownership |
2021-10-07 9:18 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Herbst Ronald Chief Scientific Officer |
0 | $0 | 397,864 (Direct) |
View |
Ownership |
2021-10-07 9:18 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXO | Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner |
0 | $0 | 2,742,338 (Direct) |
View |
Ownership |
2021-10-07 9:15 pm |
N/A 2031-09-12 |
Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer |
0 | $0 | 174,774 (Direct) |
View |
Ownership |
2021-10-07 9:10 pm |
N/A 2031-08-18 |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
0 | $0 | 15,725 (Direct) |
View |
Ownership |
2021-10-07 9:07 pm |
N/A 2031-07-30 |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
0 | $0 | 332,569 (Direct) |
View |
Ownership |
2021-10-07 9:04 pm |
N/A 2031-08-18 |
Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director |
0 | $0 | 15,725 (Direct) |
View |
Ownership |
2021-10-07 9:00 pm |
N/A 2031-08-18 |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
0 | $0 | 15,725 (Direct) |
View |
Ownership |
2021-10-07 8:56 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Chin Mark Director |
0 | $0 | 1,448,986 (Indirect) |
View |
Ownership |
2021-10-07 5:05 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 668,854 (Indirect) |
View |